PRMT3 and hepatocellular carcinoma: Since the abundance of CD8+ T cell infiltration was closely related to the efficacy of immunotherapy15, we then explored whether higher PRMT3 expression levels in pre-treatment samples were associated with poorer responses in HCC patients who received anti-PD-1/PD-L1 therapy in two independent cohorts of patients at SYSUCC.